{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:51:36Z","timestamp":1773183096512,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010218","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["EMR\/2017\/000220"],"award-info":[{"award-number":["EMR\/2017\/000220"]}],"id":[{"id":"10.13039\/501100010218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmech.2018.08.070","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T03:16:36Z","timestamp":1535426196000},"page":"1056-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"157","author":[{"given":"Srikanth","family":"Gatadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitendra","family":"Gour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetarka","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyaveni","family":"Malasala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya Sri","family":"Borra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6671-2022","authenticated-orcid":false,"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.08.070_bib1a","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health secur"},{"key":"10.1016\/j.ejmech.2018.08.070_bib1b","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"P.I.C.A.R.E. Hospitals, Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.070_bib1c","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.187","article-title":"Combating antimicrobial resistance globally","volume":"1","author":"Sugden","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.070_bib2a","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Trade"},{"key":"10.1016\/j.ejmech.2018.08.070_bib2b","first-page":"344","article-title":"The antibiotic resistance crisis: part 2: management strategies and new agents","volume":"40","author":"Ventola","year":"2015","journal-title":"Pharm. Trade"},{"key":"10.1016\/j.ejmech.2018.08.070_bib3a","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2018.08.070_bib3b","doi-asserted-by":"crossref","first-page":"195\u02d7\u02d7198","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"93","author":"Noble","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2018.08.070_bib3c","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.070_bib4a","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijmm.2017.12.002","article-title":"Differential daptomycin resistance development in Staphyloccocus aureus strains with active and mutated gra regulatory systems","volume":"308","author":"M\u00fcller","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.070_bib4b","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in\u00a0vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.070_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2018.08.070_bib6a","first-page":"983","article-title":"Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime","volume":"23","author":"Bazan","year":"2009","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.ejmech.2018.08.070_bib6b","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.05004-14","article-title":"Ceftobiprole-and ceftaroline-resistant methicillin-resistant Staphylococcus aureus","volume":"59","author":"Chan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.08.070_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"Blair","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2018.08.070_bib8","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","article-title":"Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: an update on the development of synthetic methods and pharmacological diversification","volume":"24","author":"Khan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib9a","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/acs.jmedchem.7b01474","article-title":"Quinazolinone based anticancer agents: synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure","volume":"61","author":"Dohle","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib9b","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.ejmech.2011.03.015","article-title":"Synthesis and in\u00a0vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent","volume":"46","author":"Noolvi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib9c","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s11164-017-3245-4","article-title":"Synthesis and anticancer activity of novel quinazolinone and benzamide derivatives","volume":"44","author":"EI","year":"2018","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2018.08.070_bib9d","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00044-017-2083-7","article-title":"New series of 4 (3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities","volume":"27","author":"Abbas","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.070_bib10","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2017.05.064","article-title":"Synthesis and structure\u2013activity relationship study of novel quinazolinone based inhibitors of Mur A","volume":"27","author":"Hrast","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.070_bib11a","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11030-017-9792-1","article-title":"Synthesis of novel (E)-2-(4-(1H-1, 2, 4-triazol-1-yl) styryl)-4-(alkyl\/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents","volume":"22","author":"Yang","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2018.08.070_bib11b","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.02.018","article-title":"In\u00a0vitro evaluation of new 2-phenoxy-benzo [g][1, 2, 4] triazolo [1, 5-a] quinazoline derivatives as antimicrobial agents","volume":"117","author":"Abuelizz","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejmech.2018.08.070_bib11c","first-page":"134","article-title":"Synthesis and evaluation of antifungal activities of (3H)-quinazolin-4-one derivatives against tree plant fungi","volume":"8","author":"Ighachane","year":"2017","journal-title":"J.\u00a0Mater. Environ. Sci."},{"key":"10.1016\/j.ejmech.2018.08.070_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones","volume":"121","author":"Alaa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib13a","first-page":"083","article-title":"Design, synthesis and preliminary pharmacological screening (antimicrobial, analgesic and anti-inflammatory activity) of some novel quinazoline derivatives","volume":"7","author":"Dash","year":"2017","journal-title":"J.\u00a0appl. pharm. sci."},{"key":"10.1016\/j.ejmech.2018.08.070_bib13b","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine-quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2018.08.070_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1871524917666170104142033","article-title":"Synthesis, Molecular docking and evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1,3] oxazin\/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one derivatives for their anticonvulsant activity","volume":"18","author":"Jain","year":"2018","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jhet.3099","article-title":"Synthesis and antibacterial activity of 2-substitued-(3-pyridyl)-quinazolinone derivatives","volume":"55","author":"Zhang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201700513","article-title":"Synthesis, cytotoxic, and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety","volume":"15","author":"Zhan","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2018.08.070_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00044-012-0037-7","article-title":"Synthesis, analgesic, anti-inflammatory, and in\u00a0vitro antimicrobial activities of some novel quinazolin-4 (3H)-one derivatives","volume":"22","author":"Saravanan","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.070_bib18","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/jhet.2815","article-title":"Cu-free Sonogashira type cross-coupling of 6-Halo-2-cyclopropyl-3- (pyridyl-3-ylmethyl) quinazolin-4(3H)-ones as potential antimicrobial agents","volume":"54","author":"Poudapally","year":"2017","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib19a","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.bmcl.2016.04.012","article-title":"Synthesis, biological evaluation and structure\u2013activity relationship of 2-styrylquinazolones as anti-tubercular agents","volume":"26","author":"Jadhavar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.070_bib19b","doi-asserted-by":"crossref","first-page":"30819","DOI":"10.1039\/C5RA03888J","article-title":"Convenient synthesis of 2, 3-disubstituted quinazolin-4 (3 H)-ones and 2-styryl-3-substituted quinazolin-4 (3 H)-ones: applications towards the synthesis of drugs","volume":"5","author":"Kumar","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2018.08.070_bib20","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure\u2013activity relationship for the 4 (3 H)-Quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib21","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/jacs.5b00056","article-title":"Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl) quinazolin-4 (3 H)-one","volume":"137","author":"Bouley","year":"2015","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.08.070_bib22","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1016\/j.tet.2014.07.016","article-title":"C-Triazolyl \u03b2-d-furanosides as LpxC inhibitors: stereoselective synthesis and biological evaluation","volume":"70","author":"Jana","year":"2014","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2018.08.070_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jgar.2017.04.003","article-title":"In\u00a0vitro activity of ceftolozane\/tazobactam in combination with other classes of antibacterial agents","volume":"10","author":"Jacqueline","year":"2017","journal-title":"J.\u00a0Glob. Antimicrob. Resist."},{"key":"10.1016\/j.ejmech.2018.08.070_bib24a","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejmech.2015.06.042","article-title":"Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on Imidazo[2,1-b][1,3,4]thiadiazole and Imidazo[2,1-b][1,3]thiazole Scaffolds","volume":"101","author":"Romagnoli","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib24b","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/ja0471525","article-title":"Copper (I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates","volume":"127","author":"Himo","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.08.070_bib24c","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.steroids.2010.02.015","article-title":"D-ring substituted 1, 2, 3-triazolyl 20-keto pregnenanes as potential anticancer agents: synthesis and biological evaluation","volume":"75","author":"Banday","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2018.08.070_bib24d","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.ejmech.2017.10.042","article-title":"Synthesis, antibacterial properties and 2D-QSAR studies of quinolone-triazole conjugates","volume":"143","author":"Faidallah","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib25","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard","author":"Wayne","year":"2012"},{"key":"10.1016\/j.ejmech.2018.08.070_bib26a","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.08.070_bib26b","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm0000057","article-title":"Structure\u2212function studies of polymyxin B nonapeptide:\u2009 implications to sensitization of gram-negative bacteria","volume":"43","author":"Tsubery","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.070_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.070_bib28","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2018.08.070_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2018.08.070_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2018.08.070_bib31","first-page":"38","article-title":"In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line","volume":"1","author":"Patel","year":"2009","journal-title":"Int. J. Pharm. Pharmaceut. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418307426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:56:43Z","timestamp":1759327003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418307426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"alternative-id":["S0223523418307426"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.070","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}